The case for too much regulation

• In: 5B - The regulation of pharmaceuticals has significantly increased costs without addressing the key weaknesses in the supply chain on Saturday, 6 October 2012, 12:15-13:45
• At: Amsterdam (the Netherlands) (2012)
• Type: Presentation
• By: FRANCE, Georges (Novartis, Basel, Switzerland)
• Abstract:

  No abstract available

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login